Waddell Center Experts Conduct MS Symposium
The symposium offers two different educational tracks targeted to patients, a third track targeted to caregivers, and a provider track that offers continuing medical education (CME) credits to neurologists, radiologists, emergency medicine physicians, ophthalmologists, nurses, physical therapists, occupational therapists, social workers and others who work with MS patients. Registration opens at 8:15 a.m. The first presentation will begin at 9 a.m. Patients and caregivers needing reservation information for the symposium can contact Rebekah Schraer at (513) 769-4400 or rebekah.schraer@ohg.nmss.org. For CME credit information, contact Kimberly DiPilla at (513) 558-1434 or kimberly.dipilla@uc.edu. Multiple sclerosis, an autoimmune disease that affects the central nervous system, afflicts about 400,000 Americans, at least two-thirds of them women. This is a wonderful opportunity for patients and their caregivers to receive broad and unbiased information about MS and how best to cope with it, said Presenters at the event will include Bielekova; Maria Melanson, MD, medical director of the Topics will include treatments for multiple sclerosis, developments in research, fatigue and spasticity, bowel and bladder dysfunction, depression, physical activity, intimacy and sexuality, pain, legal and financial issues, family dynamics and caregiver needs. The UC Physicians is a private-practice group of more than 400 clinical faculty members of the UC College of Medicine. The physicians provide clinical services in 18 different specialties, including primary care, surgery, internal medicine, emergency medicine, oncology, urology, cardiology, neurology, neurosurgery, rehabilitation and pain management. The Neuroscience Institute is a regional center of excellence dedicated to patient care, research, education and the development of new treatments in nine areas of neuroscience: stroke, brain and spinal tumors, epilepsy, traumatic brain and spinal injury, MS, Alzheimers disease, Parkinsons disease, disorders of the senses (swallowing, voice, hearing, pain, taste and smell), and psychiatric conditions (bipolar disorder, schizophrenia and depression).
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.